Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Arteris, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
31.8
37.9
50.4
53.7
57.7
70.6
Cost of revenue
1.49
3.73
4.28
5.08
5.96
6.9
Gross profit
30.3
34.1
46.1
48.6
51.8
63.7
Research and development
17
30.8
41.2
45.1
45
49.9
Selling and marketing
9.75
11.7
17.4
20.7
20.8
26.8
General and administrative
7.33
13.4
16.4
17.9
17.6
20.1
Operating expenses
34.1
55.9
75
83.7
83.4
96.8
Operating income
-3.78
-21.8
-28.9
-35.1
-31.6
-33.1
Interest expense
0.1
0.11
0.09
0.21
0.24
0.19
Other non-operating income
-0.05
-0.47
1.43
3.56
3.4
2.87
Pre-tax income
-2.23
-22.3
-27.8
-35.2
-31.1
-33.3
Income tax
1.03
1.04
-0.42
1.68
2.5
1.48
Net income
-3.26
-23.4
-27.4
-36.9
-33.6
-34.7
EBITDA
-2.84
-20.3
-26.8
-32.1
-28.2
-29.8
EPS, basic
-0.19
-1.06
-0.84
-1.03
-0.86
-0.82
EPS, diluted
-0.19
-1.06
-0.84
-1.03
-0.86
-0.82
Shares, basic (weighted)
17.6
22
32.6
35.7
38.9
42.3
Shares, diluted (weighted)
17.6
22
32.6
35.7
38.9
42.3
Balance sheet
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
11.7
85.8
37.4
13.7
13.7
33.9
Short-term investments
30.7
27.5
30.2
Receivables
14.4
13.9
7.14
12
20.6
19.2
Other current assets
2.86
6.95
5.82
5.25
4.63
8.61
Total current assets
29
107
81.1
58.4
69.1
82.4
Property, plant and equipment
2.37
2.44
3.62
5.75
4.02
3.87
Lease right-of-use assets
2.75
2.77
1.88
4.29
3.84
3.92
Goodwill
2.68
2.68
4.22
4.18
4.18
4.18
Intangible assets
3.41
2.96
4.58
3.86
3.02
2.17
Long-term investments
4.43
11.8
8.5
Other non-current assets
2.58
2.96
3.79
6
7.69
10.6
Total assets
42.7
120
116
103
106
115
Accounts payable
1.12
1.72
0.57
0.18
0.54
0.34
Accrued liabilities
15.9
19.1
Deferred revenue
17.9
28.4
28.8
31.5
40.4
51.4
Total current liabilities
28.2
42.5
43.7
46.4
59.3
73.2
Lease liabilities
2.08
1.85
1.01
3.61
3
3.12
Other non-current liabilities
2.99
2.16
1.02
2.41
1.64
2.47
Total liabilities
49
67.5
78
87.7
107
130
Paid-in capital
3.61
91.9
104
118
136
157
Retained earnings
-15.6
-39
-66.4
-103
-137
-172
Other comprehensive income
-0.03
-0.08
0.1
0.12
0.14
0.18
Shareholders' equity
-12
52.9
37.5
15.1
-1.19
-14.6
Total equity
-12
52.9
37.5
15.1
-1.19
-14.6
Total liabilities and equity
42.7
120
116
103
106
115
Shares outstanding
18.5
31.5
34.6
37.5
40.7
44.3
Cash flow statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-3.26
-23.4
-27.4
-36.9
-33.6
-34.7
Depreciation and amortization
0.94
1.49
2.1
3.07
3.36
3.38
Stock-based compensation
0.46
5.51
11.7
14.5
15.9
18.4
Deferred income tax
0
0.11
-0.48
0
0
-0.09
Change in receivables
-6.32
0.48
7.1
-4.86
-8.61
1.43
Change in payables
0.41
0.35
-1.03
-0.39
0.32
-0.19
Cash from operations
2.16
-0.81
-6.77
-15.7
-0.72
6.73
Capital expenditures
-0.65
-0.81
-1.05
-1.5
-0.32
-1.39
Acquisitions
-4.5
0
-1.12
0
Purchases of investments
0
-35
-47.8
-37.2
-29.5
Cash from investing
-5.15
-1.36
-37.5
-4.69
0.97
12
Stock issued
0
5.44
0
0.49
0.89
1.87
Cash from financing
0.79
76.3
-4.15
-2.92
-0.26
1.42
Net change in cash
-2.19
74.1
-48.4
-23.3
-0.01
20.2
Free cash flow
1.51
-1.62
-7.82
-17.2
-1.04
5.35
Interest paid
0.07
0.02
0
Income taxes paid
1.53
0.49
0.79
1.29
1.55
2.82
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $23.89 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
87.6%
Gross profit / revenue.
Operating margin
-47.7%
Operating income / revenue.
EBITDA margin
-42.4%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-48.4%
Pre-tax income / revenue.
Net margin
-46.7%
Net income / revenue.
FCF margin
8.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
10.1%
Cash from operations / revenue.
Return on equity (ROE)
-58.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-17.6%
Net income / average total assets.
R&D / revenue
67.5%
Research and development expense / revenue.
Stock-based pay / revenue
25.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
2.1%
Capital expenditures / revenue.
D&A / revenue
5.4%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
22.3%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
11.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
17.3%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
23.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
11.4%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
16.0%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y
25.5%
Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 5y
28.8%
Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
8.4%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-0.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
21.9%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
8.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
9.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
19.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.57x
Current assets / current liabilities.
Quick ratio
1.16x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.00x
(Cash + short-term investments) / current liabilities.
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.84
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.79
Revenue / diluted weighted shares.
FCF per share
$0.14
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.18
Cash from operations / diluted weighted shares.
Book value per share
$1.38
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
13.9x
Market cap / revenue.
P/B
17.4x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
86.3x
Market cap / tangible book value, when positive.
P/FCF
174x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
138x
Market cap / cash from operations, when positive.
EV/Sales
12.8x
Enterprise value / revenue.
EV/FCF
160x
Enterprise value / free cash flow, when both are positive.
FCF yield
0.6%
Free cash flow / market cap.
Earnings yield
-3.4%
Net income / market cap (the inverse of P/E).
What was Arteris, Inc.'s revenue in fiscal 2025?
Arteris, Inc. reported revenue of $70.6M for fiscal 2025, 22.3% higher than the year before.
Was Arteris, Inc. profitable in fiscal 2025?
No. It reported a net loss of $34.7M.
How much free cash flow did Arteris, Inc. generate in fiscal 2025?
Cash from operations of $6.7M minus capital expenditures of $1.4M left free cash flow of $5.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.